Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSuccessful Salvage Treatment of Scedosporium apiospermum Keratitis with Topical Voriconazole After Failure of Natamycin
Annals of Pharmacotherapy, 05/13/09
Al-Badriyeh D et al. - The voriconazole 1% eye drop used alone is a promising, cost-effective, safe option for managing fungal keratitis, even that caused by S. apiospermum. It may have a larger role to play than simply that of adjunctive therapy.
Related Articles
Successful Use of Topical Voriconazole 1% Alone as First-Line Antifungal Therapy Against Candida albicans Keratitis
Annals of Pharmacotherapy, 10/28/09
Relevance Score: 89%
Rapid detection of fungal keratitis using DNA-stabilizing FTA filter paper
Investigative Ophthalmology and Visual Science, 11/04/09
Relevance Score: 87%
Fungal Keratitis With Intracameral Extension Following Penetrating Keratoplasty
Cornea, 10/14/09
Relevance Score: 87%
Corneal neovascularization during experimental fungal keratitis
Molecular Vision, 10/01/09
Relevance Score: 87%
Burkholderia cepacia keratitis with endophthalmitis
Journal of Medical Microbiology, 10/21/09
Relevance Score: 85%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
Journal of Clinical Pharmacy and Therapeutics, 03/19/10
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
Cochrane Reviews, 03/19/10
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
Journal of Clinical Pharmacy and Therapeutics, 03/19/10
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
PharmacoEconomics, 03/16/10
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
European Journal of Clinical Pharmacology, 03/16/10
Article Search
Sponsor
Sponsor